Member Info for HarChris

You should take that up with the US government, they seem pretty keen on the idea.

Funnily enough that's my plan as I reduce here, to move at least some of it into Polar.

I take your point Ghia, thanks. I'm going to keep track of it myself now. A few on here including ShareSting continue to claim that there's a big buyer in the background and expecting a TR1 soon, let's hope that proves true next week.

Big, the placing raised £80m so something like 45 million shares. The increase according to MorningStar is a fraction of that.

2.5%, 5 million shares in fact.

What can you garner from this Ghia? Instantly I see they haven't updated the extra 2.5 million shares Polar has acquired so just wondering how useful the rest is?

Where did he say that? Not LSE. According to his twitter he's sold out of synairgen (and DDDD) and moved it all in to the beaten up novacyt share price. Did the opposite myself, got out of ncyt in time and moved it all into this baby!

I saw a couple of others on here saying they'd sold some of their sng shares with a plan to get in closer to results. Good news for us as it shows that company will have lots of extra support to drive the share price once things start moving for real...

No that was last Sunday or the one before and it just turned out to be a line covering the rise of 'covid stocks'. It would be nice to get a proper piece in the Sundays, perhaps a big piece on the US government's involvement...

Rewatching the proactive interview makes me think there is a decent chance of emergency approval earlier than the summer. We know there were a good number of weeks between our p2 results and the announcement of a placing to raise funds for the p3 where discussions would have been had regarding emergency approval. It's likely Richard pushed for that but was told the small p2 was simply not enough. Having had those discussions it's surely going to be revisited with early data from Activ 2 giving reason for an interim analysis of p3...

It felt to me like he's pushing towards the earlier approval route on condition that the p3 completes and full data from that being available in the summer. Yes plan A , the main course is p3 with a little side helping of Plan B. He'll soon be in the position to say 'look at all this data we're generating, look at the stubborn number of daily deaths, look at the safety profile (Holgate stated zero side effects), is this not an obvious decision???'

In regards to the Activ 2 phase 2, the first part must surely be a formality and all that is required is proof of concept/safety? If so we could be informed a few weeks after its started that the trial is being expanded to 600 with the data being constantly monitored. That would drive the share price north for sure.

Look, it costs what Scinv says it costs, not synairgen/RM, okay?

I'm dreaming of a takeover offer landing in February that we dismiss en masse. That'll stick a rocket under the sp without a doubt!

At a healthy 660k shares Richard should hopefully be enjoying a rather relaxing early retirement with Mrs RM in the not too distant future.

I was referring to Katie not Goldman Sachs, but you make a good point.

Anything keeping Buzz fit, happy and healthy right now should be supported by us.

Org, some of your analysis borders on the insane - you take overanalysis to a whole new level! I know you think it's good to question everything but some things, like the reasons why a poster might leave a BB, are just futile and pointless!

Comments like 'closing of an account means he didn’t want to be traced .... ' are simply hilarious! pmjh is a private investor with great search engine skills not some secret CIA operative!

Tyla I thought you were joking, not part of the weird pmjh conspiracy theory. He was about as bullish as anyone on this bb (well besides Zwart) and almost certainly didn't sell out at £1.90. It is possible to close an LSE account whilst continuing to invest you know!

I did think synairgen had a genuine case that might garner some support - biotech minnow up against big pharma, David & Goliath, and those same culprits Citadel take advantage by shorting the stock. A 0.5% short position (reduced to 0.39) is not quite in the same league though.

That's good news, the timing could work out to be quite advantageous. Mid March we could be in a situation where we have confirmation of the last patient being dosed in the p3 trial, results from p2 arm of Activ 2 due any day (although that'll prob be much faster) and At Home results just a few weeks away. Those, including me, surprised that we haven't strolled past £2 can at least be hopeful that we'll see a gear change soon...

Thanks a lot for that Matterhorn. So in your opinion are we looking at scenario 1, scenario 2, or somewhere in between?